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A B S T R A C T
Coenzyme Q (CoQ) is an essential cofactor, primarily found in the mitochondrial inner membrane where it
functions as an electron carrier in the respiratory chain, and as a lipophilic antioxidant. The redox state of the
CoQ pool is the ratio of its oxidised (ubiquinone) and reduced (ubiquinol) forms, and is a key indicator of
mitochondrial bioenergetic and antioxidant status. However, the role of CoQ redox state in vivo is poorly un-
derstood, because determining its value is technically challenging due to redox changes during isolation, ex-
traction and analysis. To address these problems, we have developed a sensitive liquid chromatography-tandem
mass spectrometry (LC-MS/MS) assay that enables us to extract and analyse both the CoQ redox state and the
magnitude of the CoQ pool with negligible changes to redox state from small amounts of tissue. This will enable
the physiological and pathophysiological roles of the CoQ redox state to be investigated in vivo.
1. Introduction
Coenzyme Q (CoQ) is a hydrophobic respiratory chain component
within the mitochondrial inner membrane that is also found to a far
lesser extent in other membranes [1] (Fig. 1a). The final steps of CoQ
biosynthesis take place in mitochondria, where the redox active ben-
zoquinone headgroup is linked to an isoprenyl chain in which the
number of isoprenoid units varies with species: in yeast it is CoQ6, in
rodents it is mainly CoQ9 with some CoQ10, while in humans CoQ10
predominates over CoQ9 [1–5]. Within the mitochondrial inner mem-
brane CoQ collects electrons from dehydrogenases, notably complexes I
and II (Fig. 1a), during which the ubiquinone form, CoQ, undergoes
two-electron reduction to ubiquinol (CoQH2) (Fig. 1b). The CoQH2 is
then reoxidised to CoQ at complex III to enable the respiratory chain to
reduce O2 to water while pumping protons across the inner membrane
to establish the protonmotive force (Δp) that drives ATP synthesis by
oxidative phosphorylation [1,6] (Fig. 1a). In addition to complexes I
and II, a number of other dehydrogenases also feed electrons into the
CoQ pool from diverse metabolic pathways [1,7] (Fig. 1c). As well as its
role in the respiratory chain, CoQH2 is also an important antioxidant
within the mitochondrial inner membrane where it acts as a chain
breaking antioxidant to prevent lipid peroxidation [1–5].
Thus, the CoQ pool plays a central role in mitochondrial function
and is the organelle's principal point of contact with many other me-
tabolic pathways. Consequently CoQ deficiency contributes to mi-
tochondrial dysfunction, disease and ageing [8–10]. The redox state of
the CoQ pool is the ratio of its reduced (CoQH2) and oxidised (CoQ)
forms, and is a key indicator of mitochondrial bioenergetic and anti-
oxidant status. The CoQ redox state alters dynamically in response to its
relative rates of reduction by dehydrogenases and oxidation by complex
III or by reactive oxygen species (ROS). Changes in the CoQ redox state
are central to mitochondrial redox signalling in oxygen sensing [11]
and inflammation [12,13] and also to the tissue damage associated with
ischaemia reperfusion injury [14–16]. Therefore, the CoQ redox state is
central to health and disease and measuring it in vivo is vital.
While assessing the size of the CoQ pool in tissues in vivo is
straightforward, measuring its redox state in vivo is technically chal-
lenging. This is mainly due to the difficulty of stabilising the redox state
of the CoQ pool during isolation, extraction and analysis. In addition,
for many analytical methods large amounts of material are required,
limiting applicability. Methods based on liquid chromatography cou-
pled to electrochemical detection were used extensively in the past to
investigate CoQ levels and the CoQ redox state in biological samples
[17–20]. More recently several LC-MS/MS approaches for analysis of
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the CoQ redox state have been described [17–23]. In these protocols
single-phase CoQ extraction with relatively polar alcohols such as me-
thanol or propanol are used [17,20–23]. However, as the samples
change redox state during isolation and storage, samples have to be
analysed rapidly and in small batches. Recently, an improved protocol
was developed for the determination of the CoQ redox state in tissues
by extraction into non-polar hexane followed by analysis in acidified
ethanol [18]. While this limits oxidation, separate standard curves were
still required for the two redox states, with the CoQH2 standard curve
being a potential limitation due to oxidation of CoQH2 standards dis-
torting the CoQ redox state. Here we describe a simplified two-phase
extraction that utilises a single internal standard (IS) that generates a
stable extract in which both the redox state of the CoQ pool and its
amount can be determined. This will facilitate the analysis of both in
vitro and in vivo models and expand our understanding of the role of the
CoQ pool in health and disease.
2. Results
2.1. CoQ LC-MS/MS assay
To establish CoQ redox state detection by LC-MS/MS, CoQ9/10,
CoQ9/10H2 and d6-CoQ10 internal standard (IS) were prepared (Fig. 2a).
Precursor scans of direct infusion of methanol/ammonium formate
solutions of these compounds detected the H+ and NH4+ adducts that
gave product ions at 197 m/z for both ubiquinone and ubiquinol, and at
203 m/z for the IS (Fig. 2b). We chose to use NH4+ adducts for LC-MS/
MS analysis as they were more abundant, presumably due to higher
concentrations of NH4+ compared to H+ within the buffer and because
for both redox forms the H+ adducts showed the same mass for CoQ9
and CoQ10, making CoQ redox state analysis impossible. The proposed
fragmentation mechanism is shown in Fig. S1. LC-MS/MS analysis of
pure samples of each compound showed that the CoQ and CoQH2 were
detected in the appropriate channel (Fig. 2c). While there was some
bleed through of ubiquinone samples into the ubiquinol m/z channel,
ubiquinone and ubiquinol were readily separated by LC (Fig. 2c).
Hence, this LC-MS/MS analysis can easily separate the two redox forms,
despite a mass difference of only 2.
2.2. CoQ redox state determination
To determine the redox state of the CoQ pool it would be most
convenient to measure the ratio of the mass spectrometer response to
the two redox forms, to avoid having to construct standard curves for
both redox forms of CoQ9 and CoQ10. For this to work the relative mass
spectrometer response to CoQ and CoQH2 must be stable over a range
of concentrations and ratios of both forms. To see if this was the case,
the peak areas following analysis of equal amounts of CoQ and CoQH2
at a range of increasing total concentrations were compared (Fig. 3a).
This analysis indicated that both redox forms of CoQ9 and CoQ10 had
similar mass spectrometric responses. Furthermore, when samples
containing a range of CoQH2/CoQ ratios were assessed the LC-MS/MS
analysis also detected these ratios accurately (Fig. 3b). As the CoQH2/
CoQ ratio also determines the % reduction of the CoQ pool, we
Fig. 1. The CoQ pool in the mitochondrial inner membrane as essential link between metabolic pathways and cellular energy supply.
Various mitochondrial enzymes of diverse metabolic function feed electrons into the CoQ pool of the inner mitochondrial membrane. The electrons are then relayed
to complex III of the ETC and thereby coupled to the maintenance of Δp and ATP production. a Complex I (NADH:Ubiquinone oxidoreductase) and complex II
(succinate dehydrogenase) of the ETC chain are the canonical enzymes feeding electrons into the CoQ pool under normal conditions. The electrons are shuttled to
complex III (ubiquinol:cytochrome c oxidoreductase) to be transferred onto cytochrome c and finally oxidised by complex IV (cytochrome c oxidase). By pumping
protons from the matrix into the intermembrane space, complexes I, III & IV establish the mitochondrial protonmotive force (Δp), which is used for ATP synthesis by
complex V (ATP-synthase) and various transport processes across the inner membrane. b The two electron carrier ubiquinone is a 1,4-benzoquinone, linked to an
isoprene tail which in mammals consists of 9–10 isoprenyl subunits. Ubiquinone is reduced to ubiquinol by two electrons and acts as electron shuttle and antioxidant.
c Numerous other mitochondrial oxidoreductases, such as SQR (hydrogen sulfide:ubiquinone oxidoreductase, catabolism of hydrogen sulphide), DHODH (dihy-
droorotate dehydrogenase, pyrimidine biosynthesis), CHDH (choline dehydrogenase, choline oxidation), G3PDH (glycerol 3-phosphate dehydrogenase, glycerol-3-
phosphate shuttle), ETF-QO (electron-transferring-flavoprotein dehydrogenase, fatty acid oxidation) and PRODH (proline dehydrogenase, catabolism of proline) feed
electrons into the mitochondrial CoQ pool. The electrons are funnelled by CoQ via complex III and cytochrome c to complex IV to reduce O2 to H2O.
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Fig. 2. Method development for the detection of CoQ9/10 and CoQ9/10H2 by LC-MS/MS
a The absorbance CoQ9 and CoQ10 were characterised by spectral scanning before and after reduction with NaBrH4. Upon reduction, the characteristic absorption
maximum shifts from 275 to 290 nm b Representative precursor and product MS scans of CoQ9 and CoQ10 stocks and their reduced forms as well as the deuterated d6-
CoQ10 internal standard. Precursor scans of the characteristic fragment products were performed. The product scans were performed by fragmenting the ammonium
adduct precursors. Upon fragmentation the CoQ precursor loses its isoprene side chain and forms a tropylium ion. c Representative LC-MS/MS chromatograms
showing the m/z transitions measured simultaneously for 0.5 pmol of CoQ9, CoQ10, CoQ9H2, CoQ10H2 and d6-CoQ10. Traces are normalised to the highest peak for
each sample. CoQ9 and CoQ10 show bleed through into the transitions for CoQ9H2 and CoQ10H2, respectively. Bleed through of the CoQ9 and CoQ10 signals has been
projected in red onto the CoQ9H2 and CoQ10H2 traces to show they are separated by LC. (For interpretation of the references to colour in this figure legend, the reader
is referred to the Web version of this article.)
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replotted these data as % reduction (Fig. 3c) and also the reduction
potential for the CoQ/CoQH2 redox couple [24] (Fig. 3d). Of note, for
CoQH2/CoQ ratios of 100:1, in contrast to ratios ≤50:1, the measured
value did not match that of the input sample, indicating that at very low
CoQ reduction potentials some CoQH2 oxidation will inevitably occur.
However, these highly reduced ratios are beyond the biologically re-
levant range. These analyses showed that measurement of the un-
corrected ratio of the mass spectrometric response to both redox forms
enables simultaneous and accurate determination of the redox states of
both the CoQ9 and CoQ10 pools. We also wanted to investigate if CoQH2
has the potential to transfer electrons to CoQ following extraction, and
thereby distort the measured ratios. To do this we mixed CoQ9H2 and
CoQ10, or CoQ10H2 and CoQ9, in methanol containing 2 mM ammonium
formate and incubated for 2 h at 37°C (Figs. S2a and b). This showed
some slow oxidation of CoQH2, but this was not associated with direct
reduction of the ubiquinone of the other species (Figs. S2a and b). This
analysis showed that the oxidation of the ubiquinols was slow under
our conditions, even at 37°C, and that this oxidation was not associated
with ubiquinone reduction. Therefore, during cold storage of the
extracts oxidation of CoQH2 will have minimal effect on the CoQH2/
CoQ ratio.
2.3. CoQ9 and CoQ10 quantification
The above analysis showed that the CoQH2/CoQ redox ratio could
be measured without the requirement for standard curves, simplifying
the analysis and removing potential confounding factors of ubiquinol
oxidation during standard curve preparation. However, it is also im-
portant to determine the sizes of the CoQ9 and CoQ10 pools. To do this
we used d6-CoQ10 as an IS which was synthesised by base-catalysed
exchange of the methoxy groups of CoQ10 dissolved in hexane-CD3OD.
This generated pure compound that could be used as an internal stan-
dard. The two-stage preparation described previously [19] proved un-
necessary. Using d6-CoQ10 as IS we constructed standard curves for
CoQ9 and CoQ10 (Fig. 4a and b). This enables the total amounts of CoQ9
and CoQ10 in a sample to be determined, in parallel with measurement
of their redox ratios.
Fig. 3. Determining and quantifying the ratio of
CoQ and CoQH2 by LC-MS/MS
To validate the quantification of oxidised and re-
duced CoQ, CoQ9/10 and borohydride reduced
CoQ9/10H2 stocks were mixed in predetermined ra-
tios and measured by LC-MS/MS. a Detected peak
areas of increasing amounts of CoQH2 and CoQ
mixed in a 1:1 ratio. b The detected CoQH2/CoQ
ratios were blotted against the expected theoretical
CoQH2/CoQ ratios. c The proportion of CoQH2 was
blotted against the expected theoretical CoQH2/CoQ
ratios. d The redox potential of CoQH2/CoQ mix-
tures was calculated based on the detected CoQH2/
CoQ ratios and was blotted against the expected
theoretical CoQH2/CoQ ratios. The calculations are
outlined in the methods section. Data are
mean ± S.D. of 3 replicates.
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2.4. Measurement of the CoQ redox state in mitochondria and cells
Next, we extended the CoQ extraction method to the analysis of
isolated mitochondria and cells. For bovine heart mitochondrial mem-
branes and isolated rat heart mitochondria we used a two-phase ex-
traction with ice-cold hexane and acidified methanol (Fig. 5a). This
precipitated proteins and retained many potential redox active polar
metabolites in the aqueous-methanol phase, while acidification helped
prevent oxidation of ubiquinol. Finally, extracting the CoQ pool into
hexane generated a stable solution which was then processed for mass
spectrometry.
To assess the efficacy of this procedure we measured the CoQ redox
state in bovine mitochondrial membranes, which contain pre-
dominantly CoQ10, respiring on NADH or succinate in the presence of
various inhibitors (Fig. 5b). Membranes respiring on NADH or succinate
had a CoQ pool of about 56–60% reduced. With NADH the complex I
inhibitor rotenone decreased this to ~4% reduced (Fig. 5c), while with
succinate the complex II inhibitor malonate also maintained an oxidised
CoQ pool of ~12% reduced (Fig. 5d). Addition of the complex IV in-
hibitor KCN led the CoQ pool to be ~80% reduced (Fig. 5c and d).
Incubating membranes at 37°C in the absence of substrates led to
complete oxidation of the CoQ pool, which can subsequently be re-
duced to ~60% by NADH (Fig. 5e).
We next examined isolated rat heart mitochondria, which contain
mainly CoQ9. Mitochondria respiring on glutamate/malate to generate
NADH led to reduction of the CoQ pool (Fig. 5f). The CoQ pool was
oxidised by blocking complex I with rotenone and increased to ~77%
reduction upon addition of KCN. Using succinate as a substrate also led
to CoQ reduction that was decreased by malonate and increased by
KCN. Addition of the uncoupler FCCP to abolish Δp and thereby sti-
mulate respiration oxidised the CoQ pool (Fig. 5g).
To assess CoQ in a monolayer of C2C12 cells in culture we first
rapidly washed the cell layer and then scraped the cells into cold PBS
before extraction. As C2C12 cells are derived from mice, CoQ9 is the
predominant form of CoQ. Cells showed a similar steady state CoQ
redox state to isolated mitochondria, and this was oxidised by blocking
complexes I and II with rotenone and TTFA, respectively (Fig. 5h).
Uncoupling mitochondria with FCCP oxidises the CoQ pool due to in-
creased respiration, and blocking complex III with antimycin led to
reduction of the CoQ pool (Fig. 5h).
In all three systems, there was a dominant CoQ species, either CoQ9
or CoQ10, along with a far smaller amount of the other form. The redox
state of the major form is reported above, but the method detected both
forms accurately. In all cases the redox state of the major and minor
CoQ species were the same, suggesting that both pools come to the
same redox state (Figs. S3a–f).
2.5. Measurement of the CoQ redox state in vivo
We next extended the two-phase extraction to assess CoQ redox
state in vivo. To do this we focussed on the mouse heart and liver as
these are important tissues in which the CoQ redox state is important in
health and disease. In assessing tissues, it is vital to freeze the tissue as
rapidly as possible so that the measured CoQ redox state accurately
Fig. 4. Standard curve for the quantification of the CoQ pool size by LC-MS/MS
Representative standard curve or oxidised CoQ9 (a) and CoQ10 (b). The MS response of increasing concentrations of CoQ9 and CoQ10 was compared to 0.5 pmol of d6-
CoQ10 (internal standard, IS). Data are mean ± S.D. of 3 replicates. The grey-shaded section of the standard curve on the left is expanded and replotted in the right
panel.
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reflects that in vivo. To illustrate this, heart or liver tissue was excised
either from terminally anaesthetized mice after thoracotomy, or after
cervical dislocation and then rapidly frozen in a Wollenberger clamp at
liquid nitrogen temperature. The frozen tissue was then homogenised in
ice-cold acidified methanol and hexane and analysed by LC-MS/MS
(Fig. 6a).
We first determined how well this procedure extracted CoQ from the
tissue (Figs. 6b, S4a,b). This was done by re-extracting the heart and
liver tissue and seeing how much residual CoQ was extracted (Figs. 6b,
S4a,b). This showed that the first extraction removed ~75–80% of the
CoQ pool. While subsequent extractions could remove a bit more, it was
decided not to include a second extraction routinely.
We next quantified the CoQ pool in heart and liver and found
~1.2 nmol CoQ9 and ~0.12 nmol CoQ10 per mg protein in heart
(Fig. 6c). In the liver the CoQ pools are much smaller with ~250 pmol
CoQ9 and ~6 pmol CoQ10 per mg protein (Fig. 6c). These values are
consistent with the previously reported values [25,26]. Interestingly the
CoQ9/CoQ10 ratio varied significantly between organs, being ~10 in
heart and ~42 in liver (Fig. 6d).
An important constraint in analysing the CoQ redox state is the
oxidation of extracts by air before analysis. This often requires the rapid
analysis of sample which are processed in small batches. To see if this
was a concern, we reanalysed the CoQ redox state of samples stored in
the LC-MS/MS autosampler at 8°C for up to 24 h in argon-flushed tubes.
The CoQ redox state was stable for at least 24 h in the autosampler,
confirming that large sample sets can be analysed in one run without
artefactual oxidation (Figs. 6e and S4c). The CoQ redox state was stable
without argon flushing (Fig. S4d). Nevertheless, we continued to flush
samples with argon as a precaution. We next investigated the stability
of the CoQ redox state of extracts during long-term storage at −20°C in
argon-flushed tubes. This showed that the CoQ redox state was stable
upon storage for up to at least 65 days (Fig. 6f). This allows to store and
combine separate CoQ extractions in a single analysis run.
We noticed that CoQ extracts from mouse hearts were far more
reduced than previously reported values (Fig. 6e) [18]. Consequently,
we wanted to assess whether there was any artefactual reduction of
CoQ during extraction. To do this we set up a detection protocol for d6-
CoQ10 and d6-CoQ10H2 as described in section 2.1 (Figs. S4e and f). We
then measured the reduction of d6-CoQ10 when it was spiked into the
tissue extraction solution and detected ~6% of the added d6-CoQ10 as
d6-CoQ10H2 in our extracts (Fig. S4g). In a mock extraction without
tissue ~0.8% of the added d6-CoQ10 was converted to d6-CoQ10H2. No
signal for d6-CoQ10 or d6-CoQ10H2 was detected in unspiked tissue ex-
tracts (Fig. S4g). Therefore, we conclude that a small amount of CoQ
reduction can occur during extraction. However, completely oxidised
d6-CoQ10 is thermodynamically much more prone to reduction than the
already largely reduced CoQ pools found in vivo and even if the oxidised
CoQ pool was underestimated by 5% this would have a minor effect on
the overall redox state.
Next, we wanted to determine the CoQ redox state in clamp frozen
heart. In mice killed by cervical dislocation the CoQ pool was highly
reduced at 89% and remained at a similar redox state even after 30 min
of warm ischaemia (Figs. 6g and S5a). To explore whether the tissue
collection time from cervical dislocation to clamp-freezing has an effect
on CoQ redox state, we next assessed the level of CoQ redox state in
hearts obtained from terminally anaesthetized mice. In these mice the
heart was excised directly after chest opening. This enabled a still-
beating heart to be rapidly frozen and clamped. This gave a CoQH2%
reduction of 85% (Fig. S5b), similar to that from hearts excised from
animals after cervical dislocation. The redox state of the CoQ10 pool
was also similar indicating that, as mentioned above, the two CoQ pools
are bioenergetically equivalent (Figs. 6g, S5a,b). The CoQ pool can be
fully oxidised by homogenising the heart in buffer and incubation at
37°C for 1 h (Figs. 6h and S5c). We also determined the CoQ redox state
in freshly excised and ischaemic liver and found it to be highly reduced
at 92% (Figs. 6i and S5d). As in the heart we also did not observe any
significant changes in the CoQ redox state during ischaemia in liver
(Figs. 6i and S5d). For all tested tissues the LC-MS/MS traces were clean
and the retention times of the individual CoQ species matched those of
pure CoQ (Fig. S5e).
3. Conclusions
Changes in the CoQ redox state have broad implications in the
regulation of metabolic processes, respiration and mitochondrial ROS
production. The difficulty in determining the CoQ redox state in bio-
logical samples and in vivo have been a significant impediment for the
characterisation of CoQ function within mitochondria under physiolo-
gical and pathophysiological conditions. Here we have developed a
sensitive and comparable approach to assess the CoQ redox state by LC-
MS in isolated mitochondria, cells and tissues. Applying this approach,
we are able to detect CoQ and CoQH2 at equal sensitivity, allowing
relative quantification without the need for a range of internal stan-
dards, an improvement on previous methods, which used standard
curves for both CoQ and CoQH2. In parallel, the total CoQ pool size can
be determined using only a standard curve of oxidised CoQ. In contrast
to related approaches [18], we found that while the redox states of
CoQ9 and CoQ10 can be manipulated with inhibitors and uncouplers
they were essentially the same during normal conditions in a range of
systems. Furthermore, we found that the CoQ redox state is highly
(~90%) reduced in tissues in vivo, something that was not found in
other studies, perhaps due to oxidation of the CoQ pool during ex-
traction and processing [18]. Thus our method enables the redox state
of the CoQ pool in vivo to be determined more accurately than hitherto.
Our protocol opens up new possibilities to unravel the role of the CoQ
redox state in vivo to understand the interplay between metabolism and
bioenergetics in physiological and pathophysiological processes.
4. Materials and methods
4.1. Materials
All chemicals were purchased from Sigma unless otherwise stated.
LC-MS grade Methanol was purchased from Fisher. All buffers, except
LC-MS buffers, were stored over Chelex-100. Acidified solvents were
prepared by addition of 0.1% (w/v) HCl.
Fig. 5. Extracting CoQ from biological samples and modifying the CoQ redox state in mitochondrial membranes, mitochondria and cells.
a A two-phase extraction with acidified methanol and hexane was used to extract CoQ from bovine mitochondrial membranes, mitochondria and cells. CoQ from
incubations of biological samples was extracted by vortexing in extraction solution, phase separation by centrifugation and resuspending the extract in MS sample
buffer (methanol with 2 mM ammonium formate). b Various inhibitors can be used to manipulate the mitochondrial CoQ redox state in biological samples. c-h
Bovine heart mitochondrial membranes (BHMM), rat heart mitochondria (RHM) and C2C12 cells were incubated in KPi (BHMM), KCl (RHM) buffer or DMEM (cells)
and different combinations of substrates and inhibitors were added before CoQ extraction and LC-MS/MS analysis of the CoQ redox state. All incubations were
performed for 5 min at 37°C except otherwise indicated. CoQ redox state of: c BHMM incubated with NADH or NADH combined with rotenone or KCN. d BHMM
incubated with succinate or succinate combined with malonate or KCN. e BHMM incubated for 20 min at 37°C. NADH or rotenone + NADH was added to indicated
samples after 15 min f RHM incubated with glutamate + malate (GM) or GM combined with rotenone or KCN. g RHM incubated with succinate or succinate
combined with malonate, FCCP or KCN. h C2C12 cells incubated in standard DMEM with FCCP, rotenone, TTFA or Antimycin A. For all experiments, data are
represented as mean ± S.D. of 3 replicates. The proportion of CoQH2 is shown for the indicated most prevalent CoQ species.
N. Burger, et al. Free Radical Biology and Medicine 147 (2020) 37–47
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4.2. Synthesis of d6-CoQ10
Sodium hydroxide (400 μL, 1 M in CD3OD) was added to a solution
of CoQ10 (400 mg, 0.46 mmol, 1.0 eq) in hexane (5 mL) and d4-MeOD
(4 mL). The solution was stirred at RT for 6 h then quenched with acetic
acid. The solution was extracted into diethyl ether (~20 mL), washed
with brine (2 × 75 mL), dried over sodium sulfate and concentrated
under vacuum. The residue was purified by automated column chro-
matography using a 25g SNAP ultra cartridge on a Biotage Isolera using
gradient elution from CH2Cl2:Hexane (0:100) to (80:20). The product
was recrystallised from isopropanol-diethyl ether to give the labelled
CoQ10 as an orange solid (162 mg, 40%). δH (400 MHz: CDCl3):
5.13–5.04 (9H, m, 9 × CH = ), 4.94 (1H, tq, J = 7.1 + 1.4 Hz, CH = ),
3.18 (2H, d, J = 7.0 Hz, CH2), 2.10–2.03 (16H, m, 8 × CH2), 2.01 (3H,
s, CH3), 2.00–1.93 (20H, m, 10 × CH2), 1.74 (3H, s, CH3), 1.68 (3H, s,
CH3), 1.60 (21H, broad s, 7 × CH3), 1.58 (3H, s, CH3). m/z (ESI):
Found: 891.7120. C59H84D6NaO4 requires (M + Na) +, 891.7108.
4.3. Calculation of CoQ reduction potential
The CoQ reduction potential was calculated using the following
equation, assuming a matrix pH of 7.7 [24]. Eh for the CoQ/CoQH2









4.4. Preparation of mitochondria and mitochondrial membranes
Bovine heart mitochondrial membranes were kindly provided by Dr
Hiran Prag and Prof Judy Hirst (MRC MBU) and were prepared as de-
scribed previously [27]. Female Wistar rats (Charles River) of 10–12
weeks of age were killed by stunning, followed by cervical dislocation.
Rat hearts were homogenised in STEB (250 mM sucrose, 5 mM Tris-
HCl, 1 mM EGTA, 0.1% fatty acid free BSA, pH 7.4, 4°C). Mitochondria
were isolated by differential centrifugation (2x 700×g for 5 min,
2 × 5,500×g for 10 min) at 4°C and the protein content was de-
termined by the bicinchoninic acid assay using the Pierce™ BCA Protein
assay kit with bovine serum albumin as a standard.
4.5. Mouse heart and liver experiments
All mouse experiments were carried out in accordance with the UK
Animals (Scientific Procedures) Act 1986 and the University of
Cambridge Animal Welfare policy (Project license 70/8238). Male mice
(8–10 weeks; C57BL/6J; Charles River Laboratories) were terminally
anaesthetized with sodium pentobarbital injected intraperitoneally and
ventilated with O2. Core temperature was monitored continuously via a
rectal probe. Alternatively, mice were culled by cervical dislocation. A
sternal thoracotomy was performed (heart) or the abdomen was opened
(liver) and the organ was rapidly excised and then frozen with a
Wollenberger clamp cooled in liquid nitrogen followed by storage at
−70°C. Ischaemia was induced by excising the organ and keeping it in
the abdomen or chest of the warmed mouse for indicated lengths.
Organs were then frozen and stored as described.
4.6. Reduction of ubiquinone
Ubiquinones (CoQ9, CoQ10 and d6-CoQ10) were reduced to ubiqui-
nols using sodium borohydride. All glassware was rinsed in hexane and
dried under nitrogen before use. CoQ9 or CoQ10 were made up to
10 mM in hexane, then diluted 1:10 in hexane. Solid sodium borohy-
dride was added (2 mg/100 μl) to the CoQ dilution followed by addi-
tion of methanol (to 5% v/v), vortexing for 3 min and incubation in the
dark for 5 min. The reaction was stopped by addition of 1 vol acidified
H2O with vortexing for 1 min followed by centrifugation (1,500×g,
5 min at 4°C). The CoQ-containing upper hexane layer was transferred
to a glass vial, overlaid with argon and stored at −20°C. UV scanning
spectra confirmed reduction and enabled the concentration to be cal-
culated: ε290 = 4.1 mM−1cm−1 (CoQ9H2), 4.0 mM−1cm−1 (CoQ10H2);
ε275 = 14.7 mM−1cm−1 (CoQ9), 14.6 mM−1cm−1 (CoQ10) [28].
4.7. Mass spectrometry
The mass spectrometric fragmentation patterns for the ammonium
adducts of each CoQ CoQH2 compound were determined by direct in-
fusion of 10 μM of the compound in 2 mM ammonium formate in
methanol at 2 μl/min into a triple quadrupole mass spectrometer
(Waters Xevo TQ-S). Electrospray ionisation in positive ion mode was
used as published previously with the following settings [29]: capillary
voltage – 1.7 kV; cone voltage – 30 V; ion source temperature – 100°C;
collision energy – 22 V. Nitrogen and argon were used as the curtain
and the collision gases, respectively.
4.8. Liquid chromatography tandem mass spectrometry
LC-MS/MS analyses were carried out using an I-Class Acquity LC
system attached to a Xevo TQ-S triple quadrupole mass spectrometer
(Waters) using published parameters [29]. Samples were kept at 8°C
prior to injection by the autosampler of 2–10 μl into a 15 μl flow-
through needle and RP-HPLC at 45°C using an Acquity C18 column
(2.1 × 50 mm, 1.7 μM; Waters). Mobile phase was isocratic 2 mM
ammonium formate in methanol run at 0.8 ml/min over 5 min. For MS
analysis, electrospray ionisation in positive ion mode was used as de-
scribed above. Multiple reaction monitoring in positive ion mode was
used for compound detection. Transitions used for quantification were:
CoQ9, 812.9 > 197.2; CoQ10, 880.9 > 197.2; CoQ9H2,
814.9 > 197.2; CoQ10H2, 882.9 > 197.2; d6-CoQ10, 887.0 > 203.1;
d6-CoQ10H2, 889.0 > 203.1. Standard curves were prepared using
known amounts of CoQ, which were spiked with d6-CoQ10 (IS). Stan-
dards and samples were quantified using MassLynx 4.1 software to
determine the peak area for CoQ9, CoQ10, CoQ9H2, CoQ10H2, d6-CoQ10
and d6-CoQ10H2, and the standard curves used to determine the total
amount of CoQ present in samples.
Fig. 6. Extracting CoQ from tissues and determining the CoQ redox state.
a A two-phase extraction with acidified methanol and hexane was used to extract CoQ from tissues. CoQ from clamp frozen tissue samples was extracted by
homogenising in extraction solution, phase separation by centrifugation and resuspending the extract in MS sample buffer (methanol with 2 mM ammonium
formate). b CoQ was extracted from mouse heart and liver tissue homogenates and the tissue homogenate was then reextracted. The peak areas for CoQ and CoQH2
were combined and the cumulative proportion combined with all previous extractions of the total is shown. Data are shown as mean ± S.D. of 6 different samples
from 3 different animals. c The CoQ pool size of CoQ9 and CoQ10 in mouse heart and liver. Data are shown as mean ± S.D. of 6 different samples from 3 different
animals. d The CoQ9/CoQ10 ratio in mouse heart and liver. Data are shown as mean ± S.D. of 6 different samples from 3 different animals. e CoQ redox state
changes over time (at 8°C) during several consecutive LC-MS runs (~80 min per run per sample set; final run at 24 h) in CoQ extracts of control and ischaemic mouse
hearts. The proportion of CoQH2 is represented as mean ± S.D. of 3 different hearts. f CoQ redox state changes during long term storage for up to 65 days (at −20°C)
in CoQ extracts of control mouse hearts. The proportion of CoQH2 is represented as mean ± S.D. of 3 different hearts. g CoQ redox state of control and ischaemic
mouse heart. The proportion of CoQH2 is represented as mean ± S.D. of 3 different hearts. h CoQ redox state of mouse heart tissue and tissue homogenates of the
same hearts, after oxidising the CoQ pool in KPi buffer for 1 h at 37°C. The proportion of CoQH2 is represented as mean ± S.D. of 3 different hearts. i CoQ redox state
of control and ischaemic (10 and 30 min) mouse liver. The proportion of CoQH2 is represented as mean ± S.D. of 3 different livers.
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4.9. Mitochondrial incubations
Mitochondrial membrane or rat heart mitochondria were incubated
at 15 μg protein in 100 μl KPi buffer (50 mM KPi, pH 7.8) or KCl buffer
(120 mM KCl, 10 mM HEPES, 1 mM EGTA. pH 7.2), respectively.
Substrates and inhibitors were added at the following concentrations
where indicated: 1 mM NADH, 1 mM succinate, 1 mM glutamate/ma-
late, 0.5 μM carbonyl cyanide-p-trifluoromethoxyphenylhydrazone
(FCCP), 0.5 μM rotenone, 1 mM malonate, 1 mM KCN. Samples were
incubated with shaking for 5 min or 20 min at 37°C.
4.10. Cell incubations
C2C12 mouse myoblast cells (ATCC, UK) were cultured at 37°C
under a humidified atmosphere of 5% CO2 in Dulbecco's modified
Eagles's medium (DMEM/4.5 g/l glucose + GlutaMAX, Gibco, UK)
supplemented with 10% fetal bovine serum, 100 units/ml penicillin and
100 mg/ml streptomycin. Cells (100,000) were plated 24 h prior to
experiment in 6-well plates with 2 ml medium. For experiments in-
hibitors were added at the following concentrations: 1 μM rotenone,
1 mM theonoyltrifluoroacetone (TTFA), 5 μM FCCP, 5 μM Antimycin A.
Cells were then incubated for 5 min at 37°C, washed with PBS and
scraped in 200 μl fresh PBS on ice prior to CoQ extraction.
4.11. CoQ extraction
To extract CoQ from mitochondrial membranes and mitochondria,
incubations of 100 μl containing 15 μg protein were added to ice cold
extraction solution (200 μl acidified methanol and 200 μl hexane) fol-
lowed by vortexing. To extract CoQ from cells, the cell suspension in
200 μl PBS was transferred to ice cold extraction solution (200 μl
acidified methanol and 300 μl of hexane) followed by vortexing. To
extract CoQ from tissues, 5 mg frozen tissue was weighed into cooled
lysis tubes (Precellys, CK-14) on dry ice. Then a mixture of 250 μl ice-
cold acidified methanol and 250 μl hexane was added, and tissue was
homogenised in the bullet blender (Bertin Instruments, Precellys 24) at
setting 6500 during 15 s (CK14 (1.4 mm) beads). The homogenate was
transferred to fresh 1.5 ml Eppendorf tubes. In all cases the upper, CoQ-
containing hexane layer was separated by centrifugation (5 min,
17,000×g, 4°C) and then dried down in 1 ml glass mass spectrometry
vials (186005663CV, Waters) under a stream of N2. Dried samples were
then resuspended in methanol containing 2 mM ammonium formate
and diluted (heart 1:10, liver not dilution: CoQ10 or 1:3 dilution CoQ9),
overlaid with argon and stored at −20°C until analysis. The extracts
were stable under storage for up to at least 15 days.
4.12. CoQ extraction for CoQ pool size determination
To extract CoQ from tissues, 5 mg frozen tissue was weighed into
cooled lysis tubes (Precellys, CK-14) on dry ice. Then 150 μl KPi buffer
(50 mM KPi, pH 7.8) was added and tissue was homogenised in the
bullet blender (Bertin Instruments, Precellys 24) at setting 6500 during
15 s (CK14 (1.4 mm) beads). CoQ was extracted from 100 μl of the
homogenate by adding a mixture of 250 μl ice-cold acidified methanol
and 250 μl hexane and vortexing. The upper, CoQ-containing hexane
layer was separated by centrifugation (5 min, 17,000×g, 4°C) and then
dried down in 1 ml glass mass spectrometry vials (186005663CV,
Waters) under a stream of N2. Dried samples were then resuspended in
methanol containing 2 mM ammonium formate. Heart tissue was di-
luted 1:10 (20 μl in 170 μl methanol containing 2 mM ammonium
formate and 10 μl of 5 μM d6-CoQ10 internal standard), while liver
homogenate was either not diluted (CoQ10 analysis) or diluted 1:3
(CoQ9 analysis). Samples were overlaid with argon and stored at −20°C
until analysis.
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